Suchergebnisse - "Nathan, Pradeep J"

PubPharm (305)

1

A phase 1b/2a multicenter study of the safety and preliminary pharmacodynamic effects of selective muscarinic M1 receptor agonist HTL0018318 in patients with mild-to-moderate Alzheimer's disease

enthalten in: Alzheimer's & dementia (New York, N. Y.) | 2022

von Nathan, P. | Millais, S. | Godwood, A. | +12

2

A phase 1b/2a multicenter study of the safety and preliminary pharmacodynamic effects of selective muscarinic M1 receptor agonist HTL0018318 in patients with mild‐to‐moderate Alzheimer's disease

enthalten in: Alzheimer's & Dementia: Translational Research & Clinical Interventions | 2022

von Nathan, P. | Millais, S. | Godwood, A. | +12

3

Acetylcholine prioritises direct synaptic inputs from entorhinal cortex to CA1 by differential modulation of feedforward inhibitory circuits

enthalten in: bioRxiv.org | 2021

von Palacios-Filardo, J. | Udakis, M. | Brown, G. | +5

4

Author Correction : Acetylcholine prioritises direct synaptic inputs from entorhinal cortex to CA1 by differential modulation of feedforward inhibitory circuits

enthalten in: Nature communications | 2021

von Palacios-Filardo, J. | Udakis, M. | Brown, G. | +5

ErratumFor: Nat Commun. 2021 Sep 16;12(1):5475. - PMID 34531380

5

From structure to clinic : Design of a muscarinic M1 receptor agonist with potential to treatment of Alzheimer's disease

enthalten in: Cell | 2021

von Brown, A. | Bradley, S. | Marshall, F. | +45

CommentIn: Trends Pharmacol Sci. 2022 Jun;43(6):461-463. - PMID 35101279

6

Safety, pharmacokinetics and pharmacodynamics of HTL0009936, a selective muscarinic M1 -acetylcholine receptor agonist : A randomized cross-over trial

enthalten in: British journal of clinical pharmacology | 2021

von Bakker, C. | Prins, S. | Liptrot, J. | +12

7

Acetylcholine prioritises direct synaptic inputs from entorhinal cortex to CA1 by differential modulation of feedforward inhibitory circuits

enthalten in: Nature communications | 2021

von Palacios-Filardo, J. | Udakis, M. | Brown, G. | +5

ErratumIn: Nat Commun. 2021 Dec 8;12(1):7265. - PMID 34880229

8

Spatial Covariance of Cholinergic Muscarinic M1 /M4 Receptors in Parkinson's Disease

enthalten in: Movement disorders : official journal of the Movement Disorder Society | 2021

von Colloby, S. | Nathan, P. | Bakker, G. | +5

9

First-in-man study to investigate safety, pharmacokinetics and exploratory pharmacodynamics of HTL0018318, a novel M1 -receptor partial agonist for the treatment of dementias

enthalten in: British journal of clinical pharmacology | 2021

von Bakker, C. | Tasker, T. | Liptrot, J. | +12

10

Cognitive Go/No-Go decision-making criteria in Alzheimer's disease drug development

enthalten in: Drug discovery today | 2021

von Wessels, A. | Edgar, C. | Nathan, P. | +3

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[31]